Literature DB >> 36119960

Eligibility for and Use of Oral Antimicrobial Therapy Among Veterans With Osteoarticular Infections: A Retrospective Study Across 8 Medical Centers.

Jacquelyn Mareau1, Bruce Alexander1, Jason Egge1, Brett Heintz1, Hiroyuki Suzuki1,2, Daniel J Livorsi1,2.   

Abstract

We retrospectively evaluated antimicrobial therapy in 145 randomly selected patients with osteoarticular infections across 8 hospitals. One hundred nine (75%) were eligible for oral antimicrobial therapy, but only 18 received it: 5 of 39 (13%) in 2018 versus 13 of 70 (19%) in 2019-2020 (P = .44). Oral antimicrobials may be underutilized for osteoarticular infections in routine practice. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.

Entities:  

Keywords:  oral antimicrobials; osteoarticular infections

Year:  2022        PMID： 36119960      PMCID： PMC9472666          DOI： 10.1093/ofid/ofac450

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   4.423


  17 in total

1.  Ofloxacin versus parenteral therapy for chronic osteomyelitis.

Authors:  L O Gentry; G Rodriguez-Gomez
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Managing Clinical Knowledge for Health Care Improvement.

Authors:  E A Balas; S A Boren
Journal:  Yearb Med Inform       Date:  2000

3.  Oral versus Intravenous Antibiotics for Bone and Joint Infection.

Authors:  Ho-Kwong Li; Ines Rombach; Rhea Zambellas; A Sarah Walker; Martin A McNally; Bridget L Atkins; Benjamin A Lipsky; Harriet C Hughes; Deepa Bose; Michelle Kümin; Claire Scarborough; Philippa C Matthews; Andrew J Brent; Jose Lomas; Roger Gundle; Mark Rogers; Adrian Taylor; Brian Angus; Ivor Byren; Anthony R Berendt; Simon Warren; Fiona E Fitzgerald; Damien J F Mack; Susan Hopkins; Jonathan Folb; Helen E Reynolds; Elinor Moore; Jocelyn Marshall; Neil Jenkins; Christopher E Moran; Andrew F Woodhouse; Samantha Stafford; R Andrew Seaton; Claire Vallance; Carolyn J Hemsley; Karen Bisnauthsing; Jonathan A T Sandoe; Ila Aggarwal; Simon C Ellis; Deborah J Bunn; Rebecca K Sutherland; Gavin Barlow; Cushla Cooper; Claudia Geue; Nicola McMeekin; Andrew H Briggs; Parham Sendi; Elham Khatamzas; Tri Wangrangsimakul; T H Nicholas Wong; Lucinda K Barrett; Abtin Alvand; C Fraser Old; Jennifer Bostock; John Paul; Graham Cooke; Guy E Thwaites; Philip Bejon; Matthew Scarborough
Journal:  N Engl J Med       Date:  2019-01-31       Impact factor: 91.245

4.  Oral ofloxacin versus parenteral imipenem-cilastatin in the treatment of osteomyelitis.

Authors:  M Gomis; J Barberán; B Sánchez; S Khorrami; J Borja; J García-Barbal
Journal:  Rev Esp Quimioter       Date:  1999-09       Impact factor: 1.553

5.  Factors Influencing Antibiotic-Prescribing Decisions Among Inpatient Physicians: A Qualitative Investigation.

Authors:  Daniel Livorsi; Amber Comer; Marianne S Matthias; Eli N Perencevich; Matthew J Bair
Journal:  Infect Control Hosp Epidemiol       Date:  2015-06-16       Impact factor: 3.254

6.  Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis.

Authors:  R N Greenberg; A D Tice; P K Marsh; P C Craven; P M Reilly; M Bollinger; W J Weinandt
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

Review 7.  2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults.

Authors:  Elie F Berbari; Souha S Kanj; Todd J Kowalski; Rabih O Darouiche; Andreas F Widmer; Steven K Schmitt; Edward F Hendershot; Paul D Holtom; Paul M Huddleston; Gregory W Petermann; Douglas R Osmon
Journal:  Clin Infect Dis       Date:  2015-07-29       Impact factor: 9.079

8.  Clinical Experience of Implementing Oral Versus Intravenous Antibiotics (OVIVA) in a Specialist Orthopedic Hospital.

Authors:  Tariq Azamgarhi; Ashik Shah; Simon Warren
Journal:  Clin Infect Dis       Date:  2020-09-14       Impact factor: 9.079

9.  Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy.

Authors:  Michael Marks; Lucy C K Bell; Imogen Jones; Tommy Rampling; Katharina Kranzer; Stephen Morris-Jones; Sarah Logan; Gabriele Pollara
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

10.  Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults: A WikiGuidelines Group Consensus Statement.

Authors:  Brad Spellberg; Gloria Aggrey; Meghan B Brennan; Brent Footer; Graeme Forrest; Fergus Hamilton; Emi Minejima; Jessica Moore; Jaimo Ahn; Michael Angarone; Robert M Centor; Kartikeya Cherabuddi; Jennifer Curran; Kusha Davar; Joshua Davis; Mei Qin Dong; Bassam Ghanem; Doug Hutcheon; Philipp Jent; Minji Kang; Rachael Lee; Emily G McDonald; Andrew M Morris; Rebecca Reece; Ilan S Schwartz; Miranda So; Steven Tong; Christopher Tucker; Noah Wald-Dickler; Erica J Weinstein; Riley Williams; Christina Yen; Shiwei Zhou; Todd C Lee
Journal:  JAMA Netw Open       Date:  2022-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.